x

Coronavirus

EU Official: J&J Vaccines to Arrive in April

SANT JOAN DESPÍ, Spain — A senior European Union official says 55 million doses of Johnson & Johnson’s COVID-19 vaccine will be delivered to EU member states in the second quarter of this year, starting next month.

The EU’s internal market commissioner, Thierry Breton, says the bloc will receive another 120 million doses of the single-shot jabs between July and September.

Breton spoke Friday during a visit to a plant in northeastern Spain where the vaccine developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, is being bottled. It is one of four vaccines approved for use in the EU.

Across the bloc, 52 factories are currently churning out vaccines, according to Breton. He says the EU will be producing 2 or 3 billion doses by end of year, making it the world’s top vaccine manufacturer, and allow 70% of the EU population to be inoculated by mid-July.

RELATED

LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Wellness, Longevity, Gastronomy at Navarino Challenge 2024

ATHENS – The sports tourism and wellness event Navarino Challenge returns for its 12th year, October 18-20 at Costa Navarino and Pylos.

NEW YORK (AP) — New York’s top court declined Tuesday to hear Donald Trump’s gag order appeal, leaving the restrictions in place following his felony conviction last month.

NEW YORK (AP) — Singer Justin Timberlake was arrested early Tuesday and is accused of driving while intoxicated on New York’s Long Island, authorities said.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.